A Bioequivalence Study of Two Formulations of HRS-1893 Tablets in Healthy Participants (clinicaltrials.gov) - Jun 30, 2026 - P1 | N=58 | Recruiting | Sponsor: Shandong Suncadia Medicine Co., Ltd. | N=36 ➔ 58
Enrollment change • Cardiomyopathy • Cardiovascular
|